ArticleMedicine2018

Efficacy and safety of apatinib in patients with advanced nonsmall cell lung cancer that failed prior chemotherapy or EGFR-TKIs: A pooled analysis.

Jie-Tao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.